Clinical Trials on Microscopic Colitis in Poland

Total 235 results

Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)

Ulcerative Colitis

Poland
Maria Sklodowska-Curie National Research Institute...
The Children's Memorial Health Institute, Poland; Intestinal Section of the...

Unknown

Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease (SATIMOS)

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease | Indeterminate Colitis

Poland
Vascular Biogenics Ltd. operating as VBL Therapeutics

Completed

A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis

Ulcerative Colitis

Poland, Bulgaria, Hungary
Academisch Medisch Centrum - Universiteit van Amsterdam...
University Medical Center Groningen; UMC Utrecht

Recruiting

Transfer of Feces in Ulcerative Colitis 2 (TURN2)

Ulcerative Colitis | Ulcerative Colitis Flare | Ulcerative Colitis Acute

Netherlands
Shaare Zedek Medical Center

Completed

Manipulating the Microbiome in IBD by Antibiotics and FMT (FMT)

Exacerbation of Ulcerative Colitis | Ulcerative Colitis, Active Severe | Crohn's Colitis

Israel, Italy, Canada, Finland, Poland, Spain
Hoffmann-La Roche

Terminated

A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease (FENNEL)

Crohn's Disease | Ulcerative Colitis

Poland, United Kingdom, Belgium, Spain
Abivax S.A.

Active, not recruiting

Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

Belgium, Poland, Czechia, Hungary
Adiso Therapeutics

Completed

An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC) (SCOUT)

Ulcerative Colitis

United States, Georgia, Moldova, Republic of, Poland
Novo Nordisk A/S

Terminated

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Inflammation | Ulcerative Colitis

Poland, Croatia, Denmark, Bulgaria, Hungary, Ukraine, Russian Federation
Academisch Medisch Centrum - Universiteit van Amsterdam...
Onze Lieve Vrouwe Gasthuis

Unknown

Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis (GO-KINETIC)

Ulcerative Colitis

Netherlands
Applied Molecular Transport

Completed

Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)

Ulcerative Colitis

Georgia, Netherlands, Poland, Ukraine
sigma-tau i.f.r. S.p.A.

Completed

Propionyl-L-Carnitine in Ulcerative Colitis

Ulcerative Colitis

Italy, Lithuania, Poland, Russian Federation
Academisch Medisch Centrum - Universiteit van Amsterdam...
Galapagos NV

Active, not recruiting

Early Intestinal Ultrasound in Predicting Treatment Response to Filgotinib in Ulcerative Colitis (STEER)

Ulcerative Colitis

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis

Ulcerative Colitis | Chromoendoscopy

Netherlands
Ferring Pharmaceuticals

Completed

Effectiveness of Cortiment® in Patients With Ulcerative Colitis (CORE Practice)

Ulcerative Colitis

Canada, Germany, Ireland, Italy, Netherlands, Poland, Sweden, United Kingdom
Galapagos NV

Completed

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis (SEA TURTLE)

Ulcerative Colitis

Ukraine, Georgia, Poland, Moldova, Republic of
Academisch Medisch Centrum - Universiteit van Amsterdam...
Photopill Medical Ltd

Completed

Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis (Photopill)

Ulcerative Colitis | Proctitis

Netherlands
Genentech, Inc.

Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)

Ulcerative Colitis

United States, Poland
Warner Chilcott

Terminated

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis (CAMPIII)

Ulcerative Colitis

United States, Canada, Croatia, Russian Federation, Poland, Romania
Takeda

Active, not recruiting

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland (VARIETY)

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease (IBD)

Poland
AbbVie

Completed

A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Crohn's Disease | Ulcerative Colitis (UC)

United States, Germany, Israel
Leiden University Medical Center
Galapagos NV

Recruiting

JAK Inhibition in Ulcerative Colitis

Colitis, Ulcerative

Netherlands
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

Germany, United States, Denmark, Poland
Ferring Pharmaceuticals

Completed

Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study) (OPTIMISE)

Mild-to-moderate Ulcerative Colitis

Poland, Hungary, Italy, Czechia, Netherlands, Slovakia
Telavant, Inc.
Pfizer

Completed

Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.

Colitis, Ulcerative

United States, Korea, Republic of, Belgium, Italy, Netherlands, Poland
Topivert Pharma Ltd

Completed

Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis (TOP2)

Ulcerative Colitis

Poland, Ukraine, United Kingdom, Bulgaria, Hungary, Lithuania, Czechia, Latvia
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)

Ulcerative Colitis

United States, Georgia, Germany, Hungary, Moldova, Republic of, Poland, Ukraine, United Kingdom
NImmune Biopharma

Completed

Efficacy and Safety of Oral BT-11 in Ulcerative Colitis

Ulcerative Colitis

United States, Bosnia and Herzegovina, Croatia, Poland, Ukraine
National University of Natural Medicine

Completed

Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease

Crohn's Disease | Colitis, Ulcerative

United States
Eli Lilly and Company

Recruiting

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) (SHINE-ON)

Inflammatory Bowel Diseases | Crohn's Disease | Ulcerative Colitis | Ulcerative Colitis Chronic

United States, Korea, Republic of, Poland, Italy, Japan
Shire

Completed

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Ulcerative Colitis

United States, United Kingdom, Australia, Poland, Slovakia
Galapagos NV

Completed

Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis (ORIGIN)

Ulcerative Colitis

Belgium, Czech Republic, Germany, Hungary, Poland, Russian Federation
AbbVie

Active, not recruiting

Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis

Ulcerative Colitis

United States, Japan, Poland, Slovakia, Spain, United Kingdom
Novartis Pharmaceuticals

Terminated

Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis

Colitis, Ulcerative

Russian Federation, Czechia, Bulgaria, Germany, Poland, Slovakia
Pfizer

Active, not recruiting

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

Ulcerative Colitis

United States, Poland, Germany
Warner Chilcott

Completed

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis

Ulcerative Colitis

Poland, United States, Croatia, Romania, Canada
Biogen

Completed

A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Active Ulcerative Colitis

United States, Canada, Czech Republic, Hungary, Poland, Russian Federation, Slovakia
Landos Biopharma Inc.

Recruiting

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

United States, Belgium, Italy, Poland
Warner Chilcott

Completed

Fecal Biomarker Study for Patients With Ulcerative Colitis

Ulcerative Colitis

United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis

Colitis, Ulcerative

United States, France, Belgium, Israel, Canada, Netherlands, Austria, Poland, Denmark, Germany
Eli Lilly and Company

Recruiting

A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT-URGE)

Ulcerative Colitis | Ulcerative Colitis Chronic

United Kingdom, United States, Poland, Czechia, Hungary, Italy, France, Slovakia, Germany, Belgium
Lexicon Pharmaceuticals

Completed

A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

United States, Lithuania, Poland, Slovakia
Shire

Completed

Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis (PACE)

Ulcerative Colitis

United States, United Kingdom, Israel, Canada, Hungary, Poland, Slovakia
Prometheus Biosciences, Inc., a subsidiary of Merck...

Active, not recruiting

A Phase 2 Safety and Efficacy Study of PRA023 in Subjects With Moderately to Severely Active Ulcerative Colitis (ARTEMIS-UC)

Ulcerative Colitis

United States, Australia, Belgium, Czechia, France, Georgia, Canada, Hungary, Israel, Italy, Poland, United Kingdom
Bristol-Myers Squibb

Completed

A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

Crohn Disease | Ulcerative Colitis

Romania, Italy, United States, Australia, Canada, China, Germany, Hungary, Japan, Netherlands, Poland, Portugal, Russian Federation, Spain, Taiwan, United Kingdom
Sanofi

Terminated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis (FUSCIA)

Ulcerative Colitis

United States, Austria, Canada, France, Germany, Italy, Poland
AstraZeneca
MedImmune Ltd

Completed

Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis

Ulcerative Colitis

Italy, Poland, United Kingdom, France, Czech Republic, Germany
Bristol-Myers Squibb

Terminated

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

Colitis, Ulcerative

United States, Australia, Canada, Germany, Poland, Puerto Rico, United Kingdom, Netherlands
Children's Hospital Medical Center, Cincinnati
Brown University; Seattle Children's Hospital; University of California, San... and other collaborators

Completed

Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease (PRODUCE)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis | Indeterminate Colitis

United States
sigma-tau i.f.r. S.p.A.
PRA Health Sciences

Terminated

Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study

Ulcerative Colitis

Poland, Hungary, Austria, France, Germany, Latvia, Lithuania, Spain

Clinical Trials on Microscopic Colitis in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations